248 related articles for article (PubMed ID: 17979751)
1. Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.
Komatsuzawa H; Ouhara K; Kawai T; Yamada S; Fujiwara T; Shiba H; Kurihara H; Taubman MA; Sugai M
Curr Pharm Des; 2007; 13(30):3084-95. PubMed ID: 17979751
[TBL] [Abstract][Full Text] [Related]
2. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells.
Ouhara K; Komatsuzawa H; Yamada S; Shiba H; Fujiwara T; Ohara M; Sayama K; Hashimoto K; Kurihara H; Sugai M
J Antimicrob Chemother; 2005 Jun; 55(6):888-96. PubMed ID: 15886266
[TBL] [Abstract][Full Text] [Related]
3. Salivary antimicrobial peptide expression and dental caries experience in children.
Tao R; Jurevic RJ; Coulton KK; Tsutsui MT; Roberts MC; Kimball JR; Wells N; Berndt J; Dale BA
Antimicrob Agents Chemother; 2005 Sep; 49(9):3883-8. PubMed ID: 16127066
[TBL] [Abstract][Full Text] [Related]
4. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.
Phattarataratip E; Olson B; Broffitt B; Qian F; Brogden KA; Drake DR; Levy SM; Banas JA
Mol Oral Microbiol; 2011 Jun; 26(3):187-99. PubMed ID: 21545696
[TBL] [Abstract][Full Text] [Related]
5. Human defensins and LL-37 in mucosal immunity.
Doss M; White MR; Tecle T; Hartshorn KL
J Leukoc Biol; 2010 Jan; 87(1):79-92. PubMed ID: 19808939
[TBL] [Abstract][Full Text] [Related]
6. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents.
Kruse T; Kristensen HH
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):887-95. PubMed ID: 19053901
[TBL] [Abstract][Full Text] [Related]
7. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
Findlay F; Proudfoot L; Stevens C; Barlow PG
Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
[TBL] [Abstract][Full Text] [Related]
8. Epithelial antimicrobial peptides: review and significance for oral applications.
Weinberg A; Krisanaprakornkit S; Dale BA
Crit Rev Oral Biol Med; 1998; 9(4):399-414. PubMed ID: 9825219
[TBL] [Abstract][Full Text] [Related]
9. [Physiologic and pathophysiologic significance of antimicrobial (host defensive) small peptides].
Lapis K
Orv Hetil; 2008 Dec; 149(51):2419-24. PubMed ID: 19073453
[TBL] [Abstract][Full Text] [Related]
10. Alternatives for antibiotics - antimicrobial peptides and phages.
Żelechowska P; Agier J; Kozłowska E; Brzezińska-Błaszczyk E
Przegl Lek; 2016; 73(5):334-9. PubMed ID: 29630142
[TBL] [Abstract][Full Text] [Related]
11. Defensins and LL-37: a review of function in the gingival epithelium.
Greer A; Zenobia C; Darveau RP
Periodontol 2000; 2013 Oct; 63(1):67-79. PubMed ID: 23931055
[TBL] [Abstract][Full Text] [Related]
12. Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.
Mai S; Mauger MT; Niu LN; Barnes JB; Kao S; Bergeron BE; Ling JQ; Tay FR
Acta Biomater; 2017 Feb; 49():16-35. PubMed ID: 27845274
[TBL] [Abstract][Full Text] [Related]
13. Cathelicidins and defensins regulate mast cell antimicrobial activity.
Agier J; Brzezińska-Błaszczyk E
Postepy Hig Med Dosw (Online); 2016 Jun; 70(0):618-36. PubMed ID: 27333932
[TBL] [Abstract][Full Text] [Related]
14. Perspectives for clinical use of engineered human host defense antimicrobial peptides.
Pachón-Ibáñez ME; Smani Y; Pachón J; Sánchez-Céspedes J
FEMS Microbiol Rev; 2017 May; 41(3):323-342. PubMed ID: 28521337
[TBL] [Abstract][Full Text] [Related]
15. Human antimicrobial peptides: defensins, cathelicidins and histatins.
De Smet K; Contreras R
Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
[TBL] [Abstract][Full Text] [Related]
16. Expression of defensins in gingiva and their role in periodontal health and disease.
Chung WO; Dommisch H; Yin L; Dale BA
Curr Pharm Des; 2007; 13(30):3073-83. PubMed ID: 17979750
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides: an essential component of the skin defensive barrier.
Braff MH; Gallo RL
Curr Top Microbiol Immunol; 2006; 306():91-110. PubMed ID: 16909919
[TBL] [Abstract][Full Text] [Related]
18. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands.
Mathews M; Jia HP; Guthmiller JM; Losh G; Graham S; Johnson GK; Tack BF; McCray PB
Infect Immun; 1999 Jun; 67(6):2740-5. PubMed ID: 10338476
[TBL] [Abstract][Full Text] [Related]
19. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug.
Khurshid Z; Zafar MS; Naseem M; Khan RS; Najeeb S
Curr Pharm Des; 2018; 24(10):1130-1137. PubMed ID: 29611481
[TBL] [Abstract][Full Text] [Related]
20. Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases.
Frasca L; Lande R
Curr Pharm Biotechnol; 2012 Aug; 13(10):1882-97. PubMed ID: 22250708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
